Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody
Biotech
AstraZeneca signs $247M AI-enabled oncology antibody design pact
AstraZeneca has agreed to pay Absci up to $247 million to collaborate on the design of an anti-cancer antibody.
Nick Paul Taylor
Dec 4, 2023 6:16am
Yamaha revs up new antibody profiling business Tuning Fork Bio
Sep 28, 2023 10:35am
Investors shower Star Therapeutics with $90M series C
Sep 5, 2023 7:00am
Astellas' drug against hot cancer target hits again in phase 3
Mar 22, 2023 6:30am
Astellas' intergalactic quest finds 2 pacts with Twist, Selecta
Jan 9, 2023 10:27am
AbbVie inks Immunome deal that could top $2.8B in biobucks
Jan 6, 2023 11:50am